{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:54:57Z","timestamp":1782932097354,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011500","name":"Abigail Wexner Research Institute at Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymthe.2024.10.022","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T03:04:49Z","timestamp":1730257489000},"page":"4272-4284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Liver-directed AAV gene therapy normalizes disease symptoms and provides cross-correction in a model of lysosomal acid lipase deficiency"],"prefix":"10.1016","volume":"32","author":[{"given":"Patricia","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ashbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-6191","authenticated-orcid":false,"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.10.022_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1013266","article-title":"Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease","volume":"13","author":"Besler","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2024.10.022_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/ATVBAHA.119.312136","article-title":"Lysosomal Acid Lipase in Lipid Metabolism and Beyond","volume":"39","author":"Li","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/DDDT.S149264","article-title":"Lysosomal Acid Lipase Deficiency: Therapeutic Options","volume":"14","author":"Pastores","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2018.12.006","article-title":"Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target","volume":"40","author":"Gomaraschi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.10.022_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2213988501711010001","article-title":"Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development","volume":"11","author":"Aguisanda","year":"2017","journal-title":"Curr. Chem. Genom. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib7","doi-asserted-by":"crossref","first-page":"27766","DOI":"10.1074\/jbc.270.46.27766","article-title":"Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression","volume":"270","author":"Sheriff","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.022_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/mgme.1998.2707","article-title":"Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease","volume":"64","author":"Du","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MPG.0000000000000935","article-title":"Clinical Features of Lysosomal Acid Lipase Deficiency","volume":"61","author":"Burton","year":"2015","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymthe.2024.10.022_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00322","article-title":"Hepatic Macrophages in Liver Injury","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCGENETICS.110.958728","article-title":"A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease","volume":"4","author":"Wild","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymthe.2024.10.022_bib12","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/ATVBAHA.119.313443","article-title":"Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated with Coronary Artery Disease","volume":"39","author":"Evans","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib13","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.3748\/wjg.v25.i30.4172","article-title":"Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?","volume":"25","author":"Baratta","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib14","article-title":"Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures","volume":"1864","author":"Gomaraschi","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymthe.2024.10.022_bib15","first-page":"486","article-title":"Genetic lipid storage disease with lysosomal acid lipase deficiency in rats","volume":"40","author":"Yoshida","year":"1990","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ymthe.2024.10.022_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1440-1827.1999.00862.x","article-title":"Morphological characteristics of lipid accumulation in liver-constituting cells of acid lipase deficiency rats (Wolman\u2019s disease model rats)","volume":"49","author":"Kuriwaki","year":"1999","journal-title":"Pathol. Int."},{"key":"10.1016\/j.ymthe.2024.10.022_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(11)60902-1","article-title":"Recombinant lysosomal acid lipase normalizes liver weight, transaminases and histopathological abnormalities in an in\u00a0vivo model of cholesteryl ester storage disease","volume":"54","author":"Leavitt","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib18","first-page":"E20","article-title":"Efficacy of SBC-102, a recombinant enzyme replacement therapy, across a broad range of doses in an in\u00a0vivo model of lysosomal acid lipase deficiency","volume":"52","author":"Leavitt","year":"2011","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymthe.2024.10.022_bib19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.26289","article-title":"Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease","volume":"58","author":"Balwani","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2024.10.022_bib20","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","article-title":"Enzyme therapy for lysosomal acid lipase deficiency in the mouse","volume":"10","author":"Du","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.10.022_bib21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","article-title":"Wolman disease\/cholesteryl ester storage disease: Efficacy of plant-produced human lysosomal acid lipase in mice","volume":"49","author":"Du","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2024.10.022_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2014.04.006","article-title":"Reversal of advanced disease in lysosomal acid lipase deficient mice: A model for lysosomal acid lipase deficiency disease","volume":"112","author":"Sun","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/hmg\/7.9.1347","article-title":"Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage","volume":"7","author":"Du","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.10.022_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/104303402760128586","article-title":"Lysosomal Acid Lipase Deficiency: Correction of Lipid Storage by Adenovirus-Mediated Gene Transfer in Mice","volume":"13","author":"Du","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.omtm.2022.08.001","article-title":"Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency","volume":"26","author":"Lam","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.10.022_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib27","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.022_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in\u00a0vivo but not in\u00a0vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib29","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV Vectors; Advances and Applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2275(20)31157-3","article-title":"Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span","volume":"42","author":"Du","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2024.10.022_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/adc.44.235.331","article-title":"Wolman's disease. A rare lipidosis with adrenal calcification","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymthe.2024.10.022_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lipd.12325","article-title":"Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease","volume":"57","author":"Aqul","year":"2022","journal-title":"Lipids"},{"key":"10.1016\/j.ymthe.2024.10.022_bib33","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","article-title":"Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver","volume":"91","author":"Nakai","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.022_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib35","doi-asserted-by":"crossref","first-page":"G493","DOI":"10.1152\/ajpgi.00056.2011","article-title":"Yes-associated protein is involved in proliferation and differentiation during postnatal liver development","volume":"302","author":"Septer","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1034\/j.1600-0676.2002.01702.x","article-title":"Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver","volume":"22","author":"Magami","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.ymthe.2024.10.022_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.gt.3302539","article-title":"Major role of local immune responses in antibody formation to factor IX in AAV gene transfer","volume":"12","author":"Wang","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib38","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2004-10-3867","article-title":"Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2\/8-mediated, liver-directed gene therapy","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.022_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037671","article-title":"Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy","volume":"7","author":"Sack","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.10.022_bib40","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.022_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2011.00244","article-title":"Prevention and reversal of antibody responses against factor IX in gene therapy for hemophilia B","volume":"2","author":"Nayak","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib42","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1538-7836.2011.04351.x","article-title":"Induction of tolerance to factor VIII by transient co-administration with rapamycin","volume":"9","author":"Moghimi","year":"2011","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.10.022_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib44","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-Associated Virus Vector\u2013Mediated Gene Transfer in Hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib45","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib46","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The Balance between CD8(+) T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14121","article-title":"A 14-step desensitization protocol for sebelipase alfa hypersensitivity in a patient with Wolman disease and secondary hemophagocytic lymphohistiocytosis","volume":"35","author":"Nguyen","year":"2024","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/MPG.0000000000003452","article-title":"Long-Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency","volume":"74","author":"Burton","year":"2022","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymthe.2024.10.022_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2021.10.026","article-title":"Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study","volume":"76","author":"Burton","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib50","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.ymthe.2023.02.014","article-title":"Phase I study of liver depot gene therapy in late-onset Pompe disease","volume":"31","author":"Smith","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib51","doi-asserted-by":"crossref","first-page":"11343","DOI":"10.1128\/JVI.76.22.11343-11349.2002","article-title":"A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction","volume":"76","author":"Nakai","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ymthe.2004.12.022","article-title":"Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models","volume":"11","author":"Davidoff","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2021.01.017","article-title":"Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic\/pharmacodynamic (PK\/PD) models","volume":"170","author":"Chowdhury","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.10.022_bib54","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mt.2015.99","article-title":"Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates","volume":"23","author":"Hinderer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib55","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbalip.2019.01.007","article-title":"Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation","volume":"1864","author":"Leopold","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymthe.2024.10.022_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101737","article-title":"Impact of (intestinal) LAL deficiency on lipid metabolism and macrophage infiltration","volume":"73","author":"Bianco","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101869","article-title":"Loss of lysosomal acid lipase results in mitochondrial dysfunction and fiber switch in skeletal muscles of mice","volume":"79","author":"Akhmetshina","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib58","article-title":"LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer","volume":"11","author":"Zhao","year":"2023","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.022_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105743","article-title":"Impaired lysosomal acidity maintenance in acid lipase-deficient cells leads to defective autophagy","volume":"300","author":"Moriwaki","year":"2024","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.022_bib60","article-title":"Hepatic lysosomal acid lipase drives the autophagy-lysosomal response and alleviates cholesterol metabolic disorder in ApoE deficient mice","volume":"1866","author":"Li","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymthe.2024.10.022_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2018.03.010","article-title":"Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients","volume":"124","author":"Bernstein","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa2313398","article-title":"High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman's Disease","volume":"390","author":"Eskandari","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.022_bib63","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.10.022_bib64","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.10.022_bib65","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.ymthe.2024.10.022_bib66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2024.10.022_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2013.11.003","article-title":"A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease","volume":"111","author":"Dairaku","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.10.022_bib68","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin. Chim. Acta"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:19:56Z","timestamp":1764818396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525001624006828"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-directed AAV gene therapy normalizes disease symptoms and provides cross-correction in a model of lysosomal acid lipase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}